STAT

Opinion: Traumatic brain injury should be a factor when judging individuals accused of crimes

Traumatic brain injury is common among people who are incarcerated. Since such injuries affect judgment and impulse control, individuals accused of crimes should be checked for them when they are…
An analysis of the brain of former NFL player Aaron Hernandez showed severe chronic traumatic encephalopathy — a progressive degenerative brain disease often seen in people with a history of repetitive brain trauma.

Can a traumatic brain injury increase the odds that an individual will commit a crime? And if the answer is yes, should such an injury factor into how we judge people accused of crimes?

Those questions occurred to me when I read about the latest twist in the case of Aaron Hernandez, a former tight end for the New England Patriots, who had been convicted of murdering Odin Lloyd, a semi-professional football player who had been dating the sister of Hernandez’s fiancee. While on trial for Lloyd’s murder, Hernandez was charged with shooting and killing two other men, but was acquitted in 2017. Days after that he killed himself in his prison cell.

A team of Boston University researchers was asked to examine Hernandez’s brain. — a progressive degenerative brain disease often seen in people with a history of repetitive brain trauma — they had ever seen in a person his age. While experts are using their customary scientific caution in not connecting Hernandez’s brain pathology to his crime, such severe injuries would have caused poor judgment and impulse control, two hallmarks of the bad behavior that landed Hernandez in prison for life.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks